We intend to capitalize on our management team’s background and experience to identify promising opportunities that are at the forefront of smart health technology and are enabling innovative solutions that support the transformation to value-based, precision healthcare. Specifically, we are pursuing scale-up stage operating companies that leverage modern data science to make healthcare more effective, […]

We are a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. The widespread availability of approved targeted oncology treatments, such as kinase inhibitors, has transformed the cancer treatment landscape. Despite the therapeutic benefit that targeted oncology treatments have created for some patients, the response […]

(Note: The company will change its name to DICE Therapeutics, Inc., from DiCE Molecules Holdings, LLC,  before the effectiveness of the registration statement, the prospectus says.) We are a biopharmaceutical company leveraging our proprietary technology platform, which we refer to as DELSCAPE, to build a pipeline of novel oral therapeutic candidates to treat chronic diseases […]

We intend to focus our search for a target business on companies within the Internet and technology sectors, including but not limited to, blockchain infrastructure and software services.  (Included in the Cayman Islands)  Our sponsor is Jade Value Holdings Limited, a British Virgin Islands company, managed by certain members of our management.

We currently intend to combine with Insight Guru Inc., a business and financial information technology company (doing business as Trefis), which we refer to as “Trefis,” owner of www.Trefis.com and other proprietary machine learning algorithms, databases, methodologies, and related technologies, which is partially owned by members of our sponsor, WinVest SPAC LLC, and certain members […]

We seek to acquire and operate a business in the consumer industry and we believe that our management team is well-suited to identify opportunities which have the potential to generate attractive risk-adjusted returns for our stockholders. However, we are not limited to this industry, and we may pursue a business combination opportunity in any business […]

It is our intention to pursue prospective targets that are in Asia and North America. We may pursue a business combination with a company doing business in China because certain members of our management team have connections in China, which may have legal and operational risks associated with it.  Lei Huang, our CEO and a […]

We intend to focus on operating businesses in and around the new energy, biotech, and education industries in Asia (excluding China). We shall not undertake our initial business combination with any entity with its principal business operations in China (including Hong Kong and Macau).

We are a high-growth digital customer experience solutions provider for innovative technology and other blue-chip companies. We offer omnichannel CX solutions, sales and digital marketing services and content monitoring and moderation services. We have specific expertise in providing tailored digital customer experience solutions to manage complex customer interactions that go beyond providing boilerplate responses and which require […]

We intend to focus our search on businesses in the media, advertising and entertainment industries that have their primary operations located in Asia, excluding companies operating in mainland China, Hong Kong or Macau. (Incorporated in the Cayman Islands)